Phenotype, Genotype and Biomarkers 2 | MicrobiomeTrials← Back to trialsNCT04875416
Phenotype, Genotype and Biomarkers 2
RecruitingOBSERVATIONAL
Trial Details
Start: 2021-01-08Est. Completion: 2031-09
Enrollment target: 217 participants Locations- University of Miami, Miami, Florida, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Cape Town, Cape Town, South Africa
Other microbiome trials you might be interested in
Amyotrophic Lateral Sclerosis (ALS)Chronic Respiratory FailureNeuromuscular Disease PatientsNeuromuscular DiseaseRespiratory InsufficiencyRespiratory Insufficiency Requiring Mechanical VentilationPositive Pressure VentilationNon-invasive VentilationNon-invasive Ventilation SupportNon-invasive Ventilatory Support
Amyotrophic lateral sclerosis (ALS) is a disease that causes weakness of the muscles of the body. The disease can eventu…
Hershey, United StatesEst. completion May 2029
Phase 2
Recruiting
Amyotrophic Lateral Sclerosis
The purpose of this 2-part study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyo…
Phoenix, United StatesEst. completion Oct 2026
Amyotrophic Lateral Sclerosis
The median survival of patients with amyotrophic lateral sclerosis (ALS) is 3 to 5 years and mortality is mainly related…
Montpellier, FranceCompleted Oct 21, 2025